GOAL International QuERI - Protocol CHRC 2019 GOAL INTERNATIONAL

CompletedOBSERVATIONAL
Enrollment

2,422

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Dyslipidemia
Interventions
OTHER

survey

Cross-Reference

Trial Locations (4)

31932

King Fahd Military Medical Complex, Dhahran

Unknown

Sabah Hosptial, Kuwait City

Centro de Estudios Clínicos de Querétaro (CECLIQ), Querétaro City

Cleveland Clinic, Abu Dhabi

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Amgen

INDUSTRY

lead

Dr. Anatoly Langer

OTHER

NCT03861533 - GOAL International QuERI - Protocol CHRC 2019 GOAL INTERNATIONAL | Biotech Hunter | Biotech Hunter